deltatrials
Unknown PHASE3 NCT00002858

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

PHASE III STUDY COMPARING TWO DOSES OF INDUCTION CHEMOTHERAPY FOLLOWED BY ALTERNATION OF CHEMOTHERAPY AND RADIOTHERAPY IN LIMITED SMALL CELL LUNG CANCER

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Conditions Lung Cancer
Interventions cisplatin cyclophosphamide doxorubicin hydrochloride etoposide radiation therapy
Updated 6 times since 2017 Last updated: Feb 6, 2009 Started: Mar 31, 1993

Listed as NCT00002858, this PHASE3 trial focuses on Lung Cancer and remains ongoing. Sponsored by Gustave Roussy, Cancer Campus, Grand Paris, it has been updated 6 times since 1993, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Mar 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Gustave Roussy, Cancer Campus, Grand Paris
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Angers, France, Bordeaux, France, Caen, France, Clamart, France, Corbeil, France, Créteil, France, Dijon, France, Montbéliard, France, Nantes-Saint Herblain, France, Nice, France and 6 more location s